1
|
Zhao Y, Wang Q, Deng X, Shi P and Wang Z:
Quantitative assessment of the association between GSTP1 gene
Ile105Val polymorphism and susceptibility to hepatocellular
carcinoma. Tumor Biol. 34:2121–2126. 2013. View Article : Google Scholar
|
2
|
Louaf S, Boige V, Ducreux M, Bonyhay L,
Mansourbakht T, de Baere T, Asnacios A, Hannoun L, Poynard T and
Taïeb J: Gemcitabine plus oxaliplatin (GEMOX) in patients with
advanced hepatocellular carcinoma (HCC): Results of a phase II
study. Cancer. 109:1384–1390. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS
and Jia JH: Increased Th17 cells contribute to disease progression
in patients with HBV-associated liver cirrhosis. J Viral Hepat.
19:396–403. 2012. View Article : Google Scholar : PubMed/NCBI
|
4
|
Du H, Yang W, Chen L, Shi M, Seewoo V,
Wang J, Lin A, Liu Z and Qiu W: Role of autophagy in resistance to
oxaliplatin in hepatocellular carcinoma cells. Oncol Rep.
27:143–150. 2012.PubMed/NCBI
|
5
|
Shen F and Gaffen SL: Structure-function
relationships in the IL-17 receptor: Implications for signal
transduction and therapy. Cytokine. 41:92–104. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gaffen SL: Recent advances in the IL-17
cytokine family. Curr Opin Immunol. 23:613–619. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ma Y, Aymeric L, Locher C, Mattarollo SR,
Delahaye NF, Pereira P, Boucontet L, Apetoh L, Ghiringhelli F,
Casares N, et al: Contribution of IL-17-producing gamma delta T
cells to the ecacy of anticancer chemotherapy. J Exp Med.
208:491–503. 2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lv L, Pan K, Li XD, She KL, Zhao JJ, Wang
W, Chen JG, Chen YB, Yun JP and Xia JC: The accumulation and
prognosis value of tumor infiltrating IL-17 producing cells in
esophageal squamous cell carcinoma. PLoS One. 6:e182192011.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Li Q, Han Y, Fei G, Guo Z, Ren T and Liu
Z: IL-17 promoted metastasis of non-small-cell lung cancer cells.
Immunol Lett. 148:144–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Lemancewicz D, Bolkun L, Jablonska E,
Czeczuga-Semeniuk E, Kostur A, Kloczko J and Dzieciol J: The role
of interleukin-17A and interleukin-17E in multiple myeloma
patients. Med Sci Monit. 18:BR54–BR59. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Droeser RA, Güth U, Eppenberger-Castori S,
Stadlmann S, Hirt C, Terracciano L and Singer G: High
IL-17-positive tumor immune cell infiltretion is indicative for
chemosensitivity of ovarian carcinoma. J Cancer Res Clin Oncol.
139:1295–1302. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Maitra A, Shen F, Hanel W, Mossman K,
Tocker J, Swart D and Gaffen SL: Distinct functional motifs within
the IL-17 receptor regulate signal transduction and target gene
expression. Proc Nat Acad Sci USA. 104:7506–7511. 2007. View Article : Google Scholar : PubMed/NCBI
|
13
|
Korn T: Th17 cells: Effector T cells with
inflammatory properties. Semin Immunol. 19:362–371. 2007.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Gaffen SL: Structure and signaling in the
IL-17 receptor family. Nat Rev Immunol. 9:556–567. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Okinaga T, Ariyoshi W and Akifusa S:
Essential role of JAK/STAT pathway in the induction of cell cycle
arrest in macrophages infected with periodontopathic bacterium
Aggregatibacter actinomycetemcomitans. Med Microbiol Immunol.
202:167–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Chen Y, Jiao B, Yao M, Shi X, Zheng Z, Li
S and Chen L: ISG12a inhibits HCV replication and potentiates the
anti-HCV activity of IFN-α through activation of the Jak/STAT
signaling pathway independent of autophagy and apoptosis. Virus
Res. 10:S0168–S01702. 2016.
|
17
|
Gu FM, Li QL, Gao Q, Jiang JH, Zhu K,
Huang XY, Pan JF, Yan J, Hu JH, Wang Z, et al: IL-17 induces
AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in
hepatocellular carcinoma. Mol Cancer. 10:1502011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Xu Y, An Y, Wang Y, Zhang C, Zhang H,
Huang C, Jiang H, Wang X and Li X: miR-101 inhibits autophagy and
enhances cisplatin-induced apoptosis in hepatocellular carcinoma
cells. Oncol Rep. 29:2019–2024. 2013.PubMed/NCBI
|
19
|
Harris SJ, Ciuclan L, Finan PM, Wymann MP,
Walker C, Westwick J, Ward SG and Thomas MJ: Genetic ablation of
PI3Kγ results in defective IL-17RA signalling in T lymphocytes and
increased IL-17 levels. Eur J Immunol. 42:3394–3404. 2012.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Murugaiyan G and Saha B: Protumor vs
antitumor functions of IL-17. J Immunol. 183:4169–4175. 2009.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Fortmüller K, Alt K, Gierschner D, Wolf P,
Baum V, Freudenberg N, Wetterauer U, Elsässer-Beile U and Bühler P:
Effective targeting of prostate cancer by lymphocytes redirected by
a PSMAxCD3 bispecific single-chain diabody. Prostate. 71:588–596.
2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Tesmer LA, Lundy SK, Sarkar S and Fox DA:
Th17 cells in human disease. Immunol Rev. 223:87–113. 2008.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Martin F, Apetoh L and Ghiringhelli F:
Controversies on the role of Th17 in cancer: A TGF-β-dependent
immunosuppressive activity? Trends Mol Med. 18:742–749. 2012.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Anilkumar U and Prehn JHM: Anti-apoptotic
BCL-2 family proteins in acute neural injury. Front Cell Neurosci.
30:2812014.
|
25
|
Xu Y and Lv SX: The effect of JAK2
knockout on inhibition of liver tumor growth by inducing apoptosis,
autophagy and anti-proliferation via STATs and PI3K/AKT signaling
pathways. Biomed Pharmacother. 84:1202–1212. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Tan YQ, Zhang J and Zhou G: Autophagy and
its implication in human oral diseases. Autophagy. 20:02016.
|
27
|
Cui J, Gong Z and Shen HM: The role of
autophagy in liver cancer: Molecular mechanisms and potential
therapeutic targets. Biochim Biophys Acta. 1836:15–26.
2013.PubMed/NCBI
|
28
|
Liu D, Yang Y, Liu Q and Wang J:
Inhibition of autophagy by 3-MA potentiates cisplatin-induced
apoptosis in esophageal squamous cell carcinoma cells. Med Oncol.
28:105–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Golden EB, Cho HY, Jahanian A, Hofman FM,
Louie SG, Schönthal AH and Chen TC: Chloroquine enhances
temozolomide cytotoxicity in malignant gliomas by blocking
autophagy. Neurosurg Focus. 37:E122014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Wu W, Li W, Zhou Y and Zhang C: Inhibition
of beclin1 affects the chemotherapeutic sensitivity of
osteosarcoma. Int J Clin Exp Pathol. 7:7114–7122. 2014.PubMed/NCBI
|
31
|
Moore N, Houghton J and Lyle S:
Slow-cycling therapy-resistant cancer cells. Stem Cells Dev.
21:1822–1830. 2012. View Article : Google Scholar : PubMed/NCBI
|
32
|
Jungwirth U, Xanthos DN, Gojo J, Bytzek
AK, Körner W, Heffeter P, Abramkin SA, Jakupec MA, Hartinger CG,
Windberger U, et al: Anticancer activity of methyl-substituted
oxaliplatin analogs. Mol Pharmacol. 81:719–728. 2012. View Article : Google Scholar : PubMed/NCBI
|
33
|
Shpilka T, Weidberg H, Pietrokovski S and
Elazar Z: Atg8: An autophagy-related ubiquitin-like protein family.
Genome Biol. 12:2262011. View Article : Google Scholar : PubMed/NCBI
|
34
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
35
|
Zhou YY, Li Y, Jiang WQ and Zhou LF:
MAPK/JNK signalling: a potential autophagy regulation pathway.
Biosci Rep. 35:e01992015.
|
36
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1,
2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces
tumor cell invasion in colorectal cancer cells. Neoplasia.
10:287–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
37
|
Yuan L, Wei S, Wang J and Liu X:
Isoorientin induces apoptosis and autophagy simultaneously by
reactive oxygen species (ROS)-related p53, PI3K/Akt, JNK, and p38
signaling pathways in HepG2 cancer cells. J Agric Food Chem.
62:5390–5400. 2014. View Article : Google Scholar : PubMed/NCBI
|
38
|
Jaber N, Dou Z, Chen JS, Catanzaro J,
Jiang YP, Ballou LM, Selinger E, Ouyang X, Lin RZ, Zhang J and Zong
WX: Class III PI3K Vps34 plays an essential role in autophagy and
in heart and liver function. Proc Natl Acad Sci USA. 109:2003–2008.
2012. View Article : Google Scholar : PubMed/NCBI
|
39
|
Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A,
Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX and Ye WC:
Arenobufagin, a natural bufadienolide from toad venom, induces
apoptosis and autophagy in human hepatocellular carcinoma cells
through inhibition of PI3K/Akt/mTOR pathway. Carcinogenesis.
34:1331–1342. 2013. View Article : Google Scholar : PubMed/NCBI
|
40
|
Bai R, Ding T, Zhao J, Liu S, Zhang L, Lan
X, Yu Y and Yin L: The effect of PI3K inhibitor LY294002 and
gemcitabine hydrochloride combined with ionizing radiation on the
formation of vasculogenic mimicry of Panc-1 cells in vitro and in
vivo. Neoplasma. 63:80–92. 2016. View Article : Google Scholar : PubMed/NCBI
|
41
|
Li J, Yang D, Wang W, Piao S, Zhou J,
Saiyin W, Zheng C, Sun H and Li Y: Inhibition of autophagy by 3-MA
enhances IL-24- induced apoptosis in human oral squamous cell
carcinoma cells. J Exp Clin Cancer Res. 34:972015. View Article : Google Scholar : PubMed/NCBI
|
42
|
Yamada H: Th17 cells in human rheumatoid
arthritis. Nihon Rinsho Meneki Gakkai Kaishi. 32:249–255. 2009.(In
Japanese). View Article : Google Scholar : PubMed/NCBI
|
43
|
Zou W and Restifo NP: T(H)17 cells in
tumour immunity and immunotherapy. Nat Rev Immunol. 10:248–256.
2010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Novatchkova M, Leibbrandt A, Werzowa J,
Neubüser A and Eisenhaberemail F: The STIR-domain superfamily in
signal transduction, development and immunity. Trends Biochem Sci.
28:226–229. 2003. View Article : Google Scholar : PubMed/NCBI
|
45
|
Schraml BU, Hildner K, Ise W, Lee WL,
Smith WA, Solomon B, Sahota G, Sim J, Mukasa R, Cemerski S, et al:
The AP-1 transcription factor Batf controls T(H)17 differentiation.
Nature. 460:405–409. 2009.PubMed/NCBI
|
46
|
Zhang X, Weng W, Xu W, Wang Y, Yu W, Tang
X, Ma L, Pan Q, Wang J and Sun F: Prognostic significance of
interleukin 17 in cancer: A meta-analysis. Int J Clin Exp Med.
7:3258–3269. 2014.PubMed/NCBI
|
47
|
Zhang JP, Yan J, Xu J, Pang XH, Chen MS,
Li L, Wu C, Li SP and Zheng L: Increased intratumoral
IL-17-producing cells correlate with poor survival in
hepatocellular carcinoma patients. J Hepatol. 50:980–989. 2009.
View Article : Google Scholar : PubMed/NCBI
|
48
|
Kryczek I, Banerjee M, Cheng P, Vatan L,
Szeliga W, Wei S, Huang E, Finlayson E, Simeone D, Welling TH, et
al: Phenotype, distribution, generation, and functional and
clinical relevance of Th17 cells in the human tumor environments.
Blood. 114:1141–1149. 2009. View Article : Google Scholar : PubMed/NCBI
|
49
|
Hambright HG and Ghosh R: Autophagy: In
the cROSshairs of cancer. Biochem Pharmacol. (In Press). PubMed/NCBI
|
50
|
Marin JJ, Lozano E and Perez MJ: Lack of
mitochondrial DNA impairs chemical hypoxia-induced autophagy in
liver tumor cells through ROS-AMPK-ULK1 signaling dysregulation
independently of HIF-1α. Free Radic Biol Med. 101:71–84. 2016.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Weiland A, Roswall P, Hatzihristidis TC,
Pietras K, Ostman A and Strell C: Fibroblast-dependependent
regulation of the stem cell properties of cancer cells. Neoplasma.
59:719–727. 2012. View Article : Google Scholar : PubMed/NCBI
|
52
|
Amaravadi RK, Yu D, Lum JJ, Bui T,
Christophorou MA, Evan GI, Thomas-Tikhonenko A and Thompson CB:
Autophagy inhibition enhances therapy-induced apoptosis in a
Myc-induced model of lymphoma. J Clin Invest. 117:326–336. 2007.
View Article : Google Scholar : PubMed/NCBI
|
53
|
Yuan J, Zhang Y, Sheng Y, Fu X, Cheng H
and Zhou R: MYBL2 guides autophagy suppressor VDAC2 in the
developing ovary to inhibit autophagy through a complex of
VDAC2-BECN1-BCL2L1 in mammals. Autophagy. 11:1081–1098. 2015.
View Article : Google Scholar : PubMed/NCBI
|
54
|
Xu Y, Li Z, Yin Y, Lan H, Wang J, Zhao J,
Feng J, Li Y and Zhang W: Ghrelin inhibits the differentiation of T
helper 17 cells through mTOR/STAT3 signaling pathway. PLoS One.
10:e01170812015. View Article : Google Scholar : PubMed/NCBI
|
55
|
Li P, Shi J, He Q, Hu Q, Wang YY, Zhang
LJ, Chan WT and Chen WX: Streptococcus pneumoniae Induces autophagy
through the inhibition of the PI3K-I/Akt/mTOR pathway and ROS
hypergeneration in A549 cells. PLoS One. 10:e01227532015.
View Article : Google Scholar : PubMed/NCBI
|
56
|
Aveleira CA, Botelho M, Carmo-Silva S,
Pascoal JF, Ferreira-Marques M, Nóbrega C, Cortes L, Valero J,
Sousa-Ferreira L, Álvaro AR, et al: Neuropeptide Y stimulates
autophagy in hypothalamic neurons. Proc Natl Acad Sci USA.
112:E1642–E1651. 2015. View Article : Google Scholar : PubMed/NCBI
|
57
|
Wang P, Guo QS, Wang ZW and Qian HX: HBx
induces HepG-2 cells autophagy through PI3K/Akt-mTOR pathway. Mol
Cell Biochem. 372:161–168. 2013. View Article : Google Scholar : PubMed/NCBI
|
58
|
Huang F, Kao CY, Wachi S, Thai P, Ryu J
and Wu R: Requirement for both JAK-mediated PI3K signaling and
ACT1/TRAF6/TAK1-dependent NF-κappaB activation by IL-17A in
enhancing cytokine expression in human airway epithelial cells. J
Immunol. 179:6504–6513. 2007. View Article : Google Scholar : PubMed/NCBI
|
59
|
Sun X, Zhang J, Hou Z, Han Q, Zhang C and
Tian Z: miR-146a is directly regulated by STAT3 in human
hepatocellular carcinoma cells and involved in anti-tumor immune
suppression. Cell Cycle. 14:243–252. 2015. View Article : Google Scholar : PubMed/NCBI
|
60
|
Cross-Knorr S, Lu S, Perez K, Guevara S,
Brilliant K, Pisano C, Quesenberry PJ, Resnick MB and Chatterjee D:
RKIP phosphorylation and STAT3 activation is inhibited by
oxaliplatin and camptothecin and are associated with poor prognosis
in stage II colon cancer patients. BMC Cancer. 13:4632013.
View Article : Google Scholar : PubMed/NCBI
|
61
|
Kim KW, Cho ML, Park MK, Yoon CH, Park SH,
Lee SH and Kim HY: Increased interleukin-17 production via a
phosphoinositide 3-kinase/Akt and nuclear factor kappaB-dependent
pathway in patients with rheumatoid arthritis. Arthritis Res Ther.
7:R139–R148. 2005. View
Article : Google Scholar : PubMed/NCBI
|
62
|
Huang C, Yang G, Jiang T, Huang K, Cao J
and Qiu Z: Effects of IL-6 and AG490 on regulation of Stat3
signaling pathway and invasion of human pancreatic cancer cells in
vitro. J Exp Clin Cancer Res. 29:512010. View Article : Google Scholar : PubMed/NCBI
|